Project Engage: Oral PrEP Acceptability

NCT05458765 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

330

Enrollment

OTHER

Sponsor class

Conditions

Acceptability of Health Care
Adherence, Medication

Interventions

DRUG: emtricitabine/tenofovir alafenamide
DRUG: Emtricitabine / Tenofovir Disoproxil Oral Tablet

Sponsor

Eastern Virginia Medical School

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]